Insider · CIK 0001813058
Teresa Brophy Bair
officer
Files at KURA (Kura Oncology, Inc.). First filing Jan 28, 2025, latest Sep 29, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 6
$0 bought, $427k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KURA: Kura Oncology, Inc.
KURAOct 9, 2026 · close 10.60
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 19Weak | Kura Oncology, Inc. | $89k 8,442 shares | -4% | - | |
| 40Moderate | Kura Oncology, Inc. | $95k 11,208 shares | -5% | +53% from low-30% from high | |
| 20Weak | Kura Oncology, Inc. | $98k 8,804 shares | -4% | +102% from low-32% from high | |
| 19Weak | Kura Oncology, Inc. | $79k 8,805 shares | -6% | +62% from low-54% from high | |
| 3Weak | Kura Oncology, Inc. | $9,292 1,559 shares | -1% | +11% from low-70% from high | |
| 37Weak | Kura Oncology, Inc. | $57k 7,281 shares | -6% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | KURA Kura Oncology, Inc. | SOpen-market sale Common Stock10b5-1 | -8,442 | $10.50 | $89k | 187,002 | 13 d ago |
| Jan 27, 2026 | KURA Kura Oncology, Inc. | SOpen-market sale Common Stock | -4,096 | $8.46 | $35k | 234,043 | Jan 27, 2026 |
| Jan 27, 2026 | KURA Kura Oncology, Inc. | SOpen-market sale Common Stock | -2,335 | $8.46 | $20k | 231,708 | Jan 27, 2026 |
| Jan 27, 2026 | KURA Kura Oncology, Inc. | SOpen-market sale Common Stock | -4,777 | $8.46 | $40k | 226,931 | Jan 27, 2026 |
| Jan 2, 2026 | KURA Kura Oncology, Inc. | AGrant or award Common Stock | +50,000 | $0.00 | $0 | 238,139 | Jan 6, 2026 |
| Jan 2, 2026 | KURA Kura Oncology, Inc. | AGrant or award Option to purchase common stockderivative | +100,000 | $0.00 | $0 | 100,000 | Jan 6, 2026 |
| Nov 13, 2025 | KURA Kura Oncology, Inc. | AGrant or award Common Stock10b5-1 | +48,900 | $0.00 | $0 | 196,943 | Nov 14, 2025 |
| Nov 14, 2025 | KURA Kura Oncology, Inc. | SOpen-market sale Common Stock10b5-1 | -8,804 | $11.18 | $98k | 188,139 | Nov 14, 2025 |
| Sep 27, 2025 | KURA Kura Oncology, Inc. | AGrant or award Common Stock10b5-1 | +48,900 | $0.00 | $0 | 156,848 | Sep 29, 2025 |
| Sep 29, 2025 | KURA Kura Oncology, Inc. | SOpen-market sale Common Stock10b5-1 | -8,805 | $8.94 | $79k | 148,043 | Sep 29, 2025 |
| May 19, 2025 | KURA Kura Oncology, Inc. | SOpen-market sale Common Stock10b5-1 | -1,559 | $5.96 | $9,292 | 107,948 | May 19, 2025 |
| Jan 28, 2025 | KURA Kura Oncology, Inc. | SOpen-market sale Common Stock | -2,437 | $7.87 | $19k | 112,792 | Jan 28, 2025 |
| Jan 28, 2025 | KURA Kura Oncology, Inc. | SOpen-market sale Common Stock | -4,844 | $7.87 | $38k | 107,948 | Jan 28, 2025 |
| Jan 2, 2025 | KURA Kura Oncology, Inc. | AGrant or award Common Stock | +46,250 | $0.00 | $0 | 115,229 | Jan 6, 2025 |
| Jan 2, 2025 | KURA Kura Oncology, Inc. | AGrant or award Option to purchase common stockderivative | +92,500 | $0.00 | $0 | 92,500 | Jan 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.